TG Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
321.49 |
578.51 |
850.36 |
1,072.48 |
1,416.70 |
1,652.60 |
| Przychód Δ r/r |
0.00% |
79.94% |
46.99% |
26.12% |
32.10% |
16.65% |
| Przychód (min) |
316.39 |
577.07 |
722.52 |
1,050.27 |
1,294.25 |
1,509.77 |
| Przychód (max) |
326.71 |
579.94 |
937.57 |
1,094.69 |
1,518.13 |
1,770.92 |
| EBITDA (średnia) |
-175.96 |
-316.63 |
-465.42 |
-587.00 |
-775.40 |
-904.51 |
| EBIT (średnia) |
-176.13 |
-316.94 |
-465.88 |
-587.57 |
-776.15 |
-905.39 |
| EBIT % |
-54.79% |
-54.79% |
-54.79% |
-54.79% |
-54.79% |
-54.79% |
| Zysk netto (średni) |
22.06 |
137.43 |
293.66 |
415.33 |
630.92 |
776.03 |
| Zysk netto % |
6.86% |
23.76% |
34.53% |
38.73% |
44.53% |
46.96% |
| EPS (średnia) |
0.15 |
0.86 |
1.77 |
2.42 |
3.94 |
4.84 |
| Liczba analityków (Przychody) |
5 |
4 |
7 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
5 |
6 |
5 |
4 |
3 |
2 |
| symbol |
TGTX |
TGTX |
TGTX |
TGTX |
TGTX |
TGTX |